Dr. Kathleen Prendergast, MD (she/her) is an Endocrinologist in Glen burnie, MD with over 17 years of experience. What is your opinion of Dr. Kathleen Prendergast, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Kathleen Prendergast, MD has received over $42,818 which includes payments from the following companies:
$30,278.83 from Boehringer Ingelheim Pharmaceuticals, Inc.
$7,069.33 from LILLY USA, LLC
$933.17 from sanofi-aventis U.S. LLC
$783.88 from Novo Nordisk Inc
$499.52 from Janssen Pharmaceuticals, Inc
$496.09 from AstraZeneca Pharmaceuticals LP
$347.83 from MannKind Corporation
$266.37 from Shire North American Group Inc
$192.86 from GlaxoSmithKline, LLC.
$175.92 from Corcept Therapeutics
$154.36 from AbbVie, Inc.
$129.94 from Valeritas, Inc.
$129.83 from Dexcom, Inc.
$124.57 from Becton, Dickinson and Company
$123.91 from Abbott Laboratories
$106.19 from Radius Health, Inc.
$98.29 from INSULET CORPORATION
$86.86 from Tandem Diabetes Care, Inc.
$84.50 from Merck Sharp & Dohme Corporation
$83.91 from Medtronic MiniMed, Inc.
Payments received by Dr. Kathleen Prendergast, MD were from the following categories:
$27,187.80 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!